Taken together, these findings demonstrate the significance of CD8+ TIL, TAM and TAN in dictating melanoma disease progression and treatment outcome, and in turn highlight the importance of controlling the entry of subsets of these immune cells into the tumour, which leads us to consider the role of the endothelium. Here, CD8A is linked to melanoma.